Target & Activity
| Target | Activity | Value |
|---|---|---|
| Trx-1 |
Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| A549 | IC50 | > 20 μM | Cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay | [PMID: 36657375] |
| HeLa | IC50 | 9 μM | Cytotoxicity against human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay | [PMID: 36657375] |
| HepG2 | IC50 | 12 μM | Cytotoxicity against human HepG2 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay | [PMID: 36657375] |
| HT-29 | GI50 | 25 μM | Antiproliferative activity against human HT29 cells after 48 hrs by sulforhodamine B method | [PMID: 18617414] |
| M21 | GI50 | 8.3 μM | Antiproliferative activity against human M21 cells after 48 hrs by sulforhodamine B method | [PMID: 18617414] |
| MCF7 | GI50 | 8.3 μM | Antiproliferative activity against human MCF7 cells after 48 hrs by sulforhodamine B method | [PMID: 18617414] |
| T84 | IC50 | 2.11 μM | Inhibition of human recombinant thioredoxin-mediated TG2 activation expressed in T84 cells assessed as blockade of 5-biotinamidopentylamine incorporation after 3 hrs by fluorescence microscopic analysis | [PMID: 23327656] |